Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Therapeutics Wins Summary Judgment Against CTT Pharmaceuticals. CTT’s Case is Dismissed.

March 5, 2019


BURLINGTON, Ontario – March 5, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has been successful in obtaining a summary judgment against CTT...

Rapid Dose Therapeutics Corp. Announces Amalgamation with its Wholly-Owned Subsidiary, Rapid Dose Therapeutics Inc.

March 4, 2019


Burlington, Ontario — Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce the completion of a vertical amalgamation (the “Amalgamation”) with its wholly-owned subsidiary, Rapid Dose Therapeutics Inc., pursuant to section 177 of the Business Corporations Act (Ontario). The Amalgamation...

Rapid Dose Therapeutics Business Update

February 26, 2019


BURLINGTON, Ontario – February 26, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian bio-technology company focused on innovative drug delivery solutions, is pleased to provide a business update. RDT’s proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral...

Rapid Dose Therapeutics Enters into Advisory Agreement with Spinnaker Capital Markets

February 14, 2019


BURLINGTON, Ontario – February 14, 2019 – Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) is pleased to announce that it has appointed Spinnaker Capital Markets Inc. (“Spinnaker”) as its capital markets and investor relations advisor. Spinnaker is a Toronto-based advisory firm which provides public companies...

Rapid Dose Therapeutics Announces Appointment of Dr. Gabriela Radulescu as Medical Director

January 23, 2019


BURLINGTON, Ontario – January 23, 2019 – Rapid Dose Therapeutics (“RDT”) (CSE: DOSE) is pleased to announce the appointment of Dr. Gabriela Radulescu as Medical Director for RDT. Dr. Radulescu is a physician with 20 years of experience in the pharmaceutical industry. She brings to the...

Rapid Dose Therapeutics Announces Launch of its Innovative Quickstrip™ Product to the Nevada Cannabis Market Through Brand Partnership with Flower One

January 15, 2019


BURLINGTON, Ontario – January 15, 2019 – Rapid Dose Therapeutics Inc. (“RDT”) (CSE: DOSE) is pleased to announce its entered into a definitive agreement (the “Agreement”) on January 10, 2019, with Flower One Holdings Inc. (“Flower One”) (CSE: FONE) (OTCQB: FLOOF) pursuant to which Flower...

Rapid Dose Therapeutics and Aphria to Deliver Innovative Quickstrip™ Technology to the German Cannabis Market

December 18, 2018


Burlington and Leamington Ontario – December 18, 2018 – Rapid Dose Therapeutics Inc. (“RDT” or the “Company”) (CSE: DOSE) and Aphria Inc. (“Aphria”) (TSX: APHA and NYSE: APHA) announced today that they have expanded the scope of their previously announced agreement (the “Agreement”), executed  on...

Rapid Dose Therapeutics Begins Trading on the CSE Under the Ticker “DOSE”

December 17, 2018


NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.. Burlington Ontario – December 17, 2018.  Rapid Dose Therapeutics Corp. (formerly ACME Resources Corp.) (CSE: DOSE) ("RDT" or the "Corporation") is pleased to announce that, following completion of the business combination...

Acme Resources Announces Change of Name to Rapid Dose Therapeutics Corp. and Changes of Directors and Officers

December 10, 2018


Toronto, Burlington Ontario – Further to its press release of December 7, 2018, Rapid Dose Therapeutics Corp. (formerly ACME Resources Corp.) (“ACME” or the “Corporation”), is pleased to announce the change of its name from ACME Resources Corp. to Rapid Dose Therapeutics Corp. in connection...

Acme Resources and Rapid Dose Therapeutics Announce Completion of Amalgamation

December 7, 2018


Toronto, Burlington Ontario – ACME Resources Corp. (“ACME” or the “Corporation“) and Rapid Dose Therapeutics Inc. (“RDT”) are pleased to jointly announce the completion of the three-cornered amalgamation pursuant to an Amended and Restated Amalgamation Agreement (the “Amalgamation Agreement“) as of July 11, 2018 as...

1 2 3 4